Arabic Arabic English English French French German German
dark

Vividion Therapeutics Appoints Christine Siu to Board of Directors

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, today announced that Christine Siu, a life sciences industry leader with more than 20 years of experience in corporate development, strategy and financial roles, has joined the company’s board of directors. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Expansions and Hirings Spark Surge of Growth in BioCapital Region

Next Post

Sherlock Biosciences’ CRISPR SARS-CoV-2 Test Selected as Finalist in “On the Rise” and Honorable Mention in “Health and Pandemic Response” Categories of Fast Company’s 2021 World Changing Ideas Awards

Related Posts
Total
0
Share